Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing

Purinergic Signalling

Volumn 7, Issue 2, 2011, Pages 193-206

  Gendaszewska Darmach, Edyta ^a   Kucharska, Marta ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Angiogenesis; Inflammation; Nucleotides; P2 receptors; Wound healing

Indexed keywords

EID: 79961006248     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9233-z     Document Type: Review

References (120)

1. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483.
2. Browne LE, Jiang LH, North RA (2010) New structure enlivens interest in P2X receptors. Trends Pharmacol Sci 31: 229-237.
3. Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA (2000) ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Mol Pharmacol 57: 926-931.
4. Communi D, Govaerts C, Parmentier M, Boeynaems JM (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272: 31969-31973.
5. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409: 202-207.
6. i. J Biol Chem 276: 41479-41485.
7. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24: 52-55.
8. von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
9. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
10. Braun M, Lelieur K, Kietzmann M (2006) Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing in mice. Wound Repair Regen 14: 152-161.
11. Yin J, Xu K, Zhang J, Kumar A, Yu FS (2007) Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 120: 815-825.
12. Schwiebert EM, Zsembery A (2003) Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta 1615: 7-32.
13. 2 receptors. Br J Pharmacol 127: 1680-1686.
14. Burrell HE, Bowler WB, Gallagher JA, Sharpe GR (2003) Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 120: 440-447.
15. Mizumoto N, Mummert ME, Shalhevet D, Takashima A (2003) Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol 121: 1066-1072.
16. Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP (2006) Nucleotide receptor signaling in platelets. J Thromb Haemost 4: 2317-2326.
17. Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233: 309-319.
18. Dubyak GR, El-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265: C577-C606.
19. Zigmond SH (1977) Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol 75: 606-616.
20. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795.
21. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ (1996) ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 271: H2717-H2722.
22. Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26: 40-47.
23. Yegutkin G, Bodin P, Burnstock G (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129: 921-926.
24. Grierson JP, Meldolesi J (1995) Shear stress-induced [Ca2+]i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP. J Biol Chem 270: 4451-4456.
25. Bodin P, Bailey D, Burnstock G (1991) Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 103: 1203-1205.
26. Prosdocimo DA, Douglas DC, Romani AM, O'Neill WC, Dubyak GR (2009) Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. Am J Physiol Cell Physiol 296: C828-C839.
27. Bodin P, Burnstock G (1995) Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia 51: 256-259.
28. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR (2002) Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277: 44638-44650.
29. Bozzo J, Hernandez MR, Galan AM, Heras M, Ordinas A, Escolar G (1999) Impaired antiplatelet effects of aspirin associated with hypoxia and ATP release from erythrocytes. Studies in a system with flowing human blood. Eur J Clin Investig 29: 438-444.
30. Lazarowski ER, Boucher RC (2001) UTP as an extracellular signaling molecule. News Physiol Sci 16: 1-5.
31. Lazarowski ER, Boucher RC, Harden TK (2003) Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 64: 785-795.
32. Greig AV, Linge C, Terenghi G, McGrouther DA, Burnstock G (2003) Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 120: 1007-1015.
33. Yoshida H, Kobayashi D, Ohkubo S, Nakahata N (2006) ATP stimulates interleukin-6 production via P2Y receptors in human HaCaT keratinocytes. Eur J Pharmacol 540: 1-9.
34. Inoue K, Hosoi J, Denda M (2007) Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 127: 362-371.
35. Ferrari D, La Sala A, Chiozzi P, Morelli A, Falzoni S, Girolomoni G, Idzko M, Dichmann S, Norgauer J, Di Virgilio F (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J 14: 2466-2476.
36. Granstein RD, Ding W, Huang J, Holzer A, Gallo RL, Di Nardo A, Wagner JA (2005) Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants. J Immunol 174: 7725-7731.
37. Georgiou JG, Skarratt KK, Fuller SJ, Martin CJ, Christopherson RI, Wiley JS, Sluyter R (2005) Human epidermal and monocyte-derived Langerhans cells express functional P2X7 receptors. J Invest Dermatol 125: 482-490.
38. White N, Ryten M, Clayton E, Butler P, Burnstock G (2005) P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 224: 81-91.
39. White N, Butler PE, Burnstock G (2005) Human melanomas express functional P2X(7) receptors. Cell Tissue Res 321: 411-418.
40. Deli T, Varga N, Adam A, Kenessey I, Raso E, Puskas LG, Tovari J, Fodor J, Feher M, Szigeti GP, Csernoch L, Timar J (2007) Functional genomics of calcium channels in human melanoma cells. Int J Cancer 121: 55-65.
41. Solini A, Chiozzi P, Morelli A, Passaro A, Fellin R, Di Virgilio F (2003) Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport. J Cell Physiol 197: 435-444.
42. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F (1999) Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 112: 297-305.
43. Furuya K, Sokabe M, Furuya S (2005) Characteristics of subepithelial fibroblasts as a mechano-sensor in the intestine: cell-shapedependent ATP release and P2Y1 signaling. J Cell Sci 118: 3289-3304.
44. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
45. Talasila A, Germack R, Dickenson JM (2009) Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts. Br J Pharmacol 158: 339-353.
46. Sui GP, Wu C, Fry CH (2006) Characterization of the purinergic receptor subtype on guinea pig suburothelial myofibroblasts. BJU Int 97: 1327-31.
47. Liu F, Takahashi N, Yamaguchi O (2009) Expression of P2X3 purinoceptors in suburothelial myofibroblasts of the normal human urinary bladder. Int J Urol 16: 570-575.
48. Liang W, McDonald P, McManus B, van Breemen C, Wang X (2008) P2Y2 receptor-mediated Ca2+ signaling and spontaneous Ca2+ releases in human valvular myofibroblasts. Int Heart J 49: 221-36.
49. Bradding P, Okayama Y, Kambe N (2003) Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J Leukoc Biol 73: 614-620.
50. s-coupled receptor. J Immunol 173: 7539-7547.
51. Yamamoto K, Korenaga R, Kamiya A, Qi Z, Sokabe M, Ando J (2000) P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 279: 285-292.
52. Glass R, Loesch A, Bodin P, Burnstock G (2002) P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell Mol Life Sci 59: 870-881.
53. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40: 841-853.
54. Seiffert K, Ding W, Wagner JA, Granstein RD (2006) ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 126: 1017-1027.
55. Malmsjo M, Hou M, Pendergast W, Erlinge D, Edvinsson L (2003) Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3: 4.
56. Malmsjo M, Hou M, Harden TK, Pendergast W, Pantev E, Edvinsson L, Erlinge D (2000) Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5′-O-thiodiphosphate and uridine 5′-O-3-thiotriphosphate. J Pharmacol Exp Ther 293: 755-760.
57. Pillois X, Chaulet H, Belloc I, Dupuch F, Desgranges C, Gadeau AP (2002) Receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res 90: 678-681.
58. Eming SA, Brachvogel B, Odorisio T, Koch M (2007) Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 42: 115-170.
59. Gachet C (2008) P2 receptors, platelet function and pharmacological implications. Thromb Haemost 99: 466-472.
60. Verghese MW, Kneisler TB, Boucheron JA (1996) P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 271: 15597-15601.
61. Sak K, Boeynaems JM, Everaus H (2003) Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol 73: 442-447.
62. Chen Y, Shukla A, Namiki S, Insel PA, Junger WG (2004) A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J Leukoc Biol 76: 245-253.
63. Martel-Gallegos G, Rosales-Saavedra MT, Reyes JP, Casas-Pruneda G, Toro-Castillo C, Perez-Cornejo P, Arreola J (2010) Human neutrophils do not express purinergic P2X7 receptors. Purinergic Signal 6: 297-306.
64. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, Junger WG (2010) Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3: ra45.
65. Myrtek D, Idzko M (2007) Chemotactic activity of extracellular nucleotides on human immune cells. Purinergic Signal 3: 5-11.
66. Warny M, Aboudola S, Robson SC, Sevigny J, Communi D, Soltoff SP, Kelly CP (2001) P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276: 26051-26056.
67. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, Panther E, Norgauer J (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100: 925-932.
68. Bulanova E, Bulfone-Paus S (2010) P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 6: 3-17.
69. Wang L, Jacobsen SE, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5: 16.
70. Ferrari D, Idzko M, Dichmann S, Purlis D, Virchow C, Norgauer J, Chiozzi P, Di Virgilio F, Luttmann W (2000) P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. FEBS Lett 486: 217-24.
71. Sluyter R, Barden JA, Wiley JS (2001) Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304: 231-36.
72. Berchtold S, Ogilvie AL, Bogdan C, Mühl-Zürbes P, Ogilvie A, Schuler G, Steinkasserer A (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett 458: 424-28.
73. Skelton L, Cooper M, Murphy M, Platt A (2003) Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. J Immunol 171: 1941-949.
74. Mei L, Du W, Gao W, Mei QB (2010) Purinergic signaling: a novel mechanism in immune surveillance. Acta Pharmacol Sin 31: 1149-1153.
75. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112: 358-404.
76. Humphreys BD, Dubyak GR (1996) Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J Immunol 157: 5627-5637.
77. Martin KA, Kertesy SB, Dubyak GR (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 51: 97-108.
78. Janssen LJ, Farkas L, Rahman T, Kolb MR (2009) ATP stimulates Ca(2+)-waves and gene expression in cultured human pulmonary fibroblasts. Int J Biochem Cell Biol 41: 2477-2484.
79. Huang NN, Wang DJ, Heppel LA (1993) Stimulation of aged human lung fibroblasts by extracellular ATP via suppression of arachidonate metabolism. J Biol Chem 268: 10789-10795.
80. Patel GK, Wilson CH, Harding KG, Finlay AY, Bowden PE (2006) Numerous keratinocyte subtypes involved in wound re-epithelialization. J Invest Dermatol 126: 497-502.
81. Santoro MM, Gaudino G (2005) Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304: 274-286.
82. Greig AV, James SE, McGrouther DA, Terenghi G, Burnstock G (2003) Purinergic receptor expression in the regeneration epidermis in a rat model of normal and delayed wound healing. Exp Dermatol 12: 860-871.
83. Taboubi S, Milanini J, Delamarre E, Parat F, Garrouste F, Pommier G, Takasaki J, Hubaud JC, Kovacic H, Lehmann M (2007) G alpha(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration. FASEB J 21: 4047-4058.
84. Taboubi S, Garrouste F, Parat F, Pommier G, Faure E, Monferran S, Kovacic H, Lehmann M (2010) Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. Mol Biol Cell 21: 946-955.
85. Kaczmarek E, Erb L, Koziak K, Jarzyna R, Wink MR, Guckelberger O, Blusztajn JK, Trinkaus-Randall V, Weisman GA, Robson SC (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93: 735-742.
86. Yu N, Erb L, Shivaji R, Weisman GA, Seye CI (2008) Binding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells. Circ Res 102: 581-588.
87. Wang D, Huang NN, Heppel LA (1990) Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters. Biochem Biophys Res Commun 166: 251-258.
88. Waldman SD, Usprech J, Flynn LE, Khan AA (2010) Harnessing the purinergic receptor pathway to develop functional engineered cartilage constructs Osteoarthritis. Osteoarthr Cartil 18: 864-872.
89. Albert JL, Boyle JP, Roberts JA, Challiss RA, Gubby SE, Boarder MR (1997) Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase. Br J Pharmacol 122: 935-941.
90. Cha SH, Hahn TW, Sekine T, Lee KH, Endou H (2000) Purinoceptor-mediated calcium mobilization and cellular proliferation in cultured bovine corneal endothelial cells. Jpn J Pharmacol 82: 181-187.
91. Satterwhite CM, Farrelly AM, Bradley ME (1999) Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol 276: H1091-H1097.
92. Gendaszewska-Darmach E, Maszewska M, Zaklos M, Koziolkiewicz M (2003) Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures. Acta Biochim Pol 50: 973-984.
93. Erlinge D (1998) Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31: 1-8.
94. Shen J, Seye CI, Wang M, Weisman GA, Wilden PA, Sturek M (2004) Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66: 1265-1274.
95. Wilden PA, Agazie YM, Kaufman R, Halenda SP (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275: H1209-1215.
96. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279: 35679-35686.
97. Rumjahn SM, Yokdang N, Baldwin KA, Thai J, Buxton IL (2009) Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis. Br J Cancer 100: 1465-1470.
98. Hill LM, Gavala ML, Lenertz LY, Bertics PJ (2010) Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 185: 3028-3034.
99. Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K, Neal C, Krugh B, Santiago-Perez LI, Gonzalez FA, Gresham HD, Turner JT, Weisman GA (2001) An RGD sequence in the P2Y2 receptor interacts with αVβ3 integrins and is required for Go-mediated signal transduction. J Cell Biol 153: 491-501.
100. Hirakawa M, Oike M, Karashima Y, Ito Y (2004) Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium. J Physiol 558: 479-488.
101. Koyama T, Oike M, Ito Y (2001) Involvement of rho-kinase and tyrosine kinase in hypotonic stress-induced ATP release in bovine aortic endothelial cells. J Physiol 532: 759-769.
102. Woodward HN, Anwar A, Riddle S, Taraseviciene-Stewart L, Fragoso M, Stenmark KR, Gerasimovskaya EV (2009) PI3K, rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Lung Cell Mol Physiol 297: L954-L964.
103. Gerasimovskaya EV, Woodward HN, Tucker DA, Stenmark KR (2008) Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis 11: 169-182.
104. Lyubchenko T, Woodward HN, Veo KD, Burns N, Nijmeh H, Liubchenko GA, Stenmark KR, Gerasimovskaya EV (2011) P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Cell Physiol 300: C266-C75.
105. Valls MD, Cronstein BN, Montesinos MC (2009) Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol 77: 1117-1124.
106. Gu BJ, Wiley JS (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107: 4946-4953.
107. Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40: 1334-1347.
108. Zhang Y, Gong LH, Zhang HQ, Du Q, You JF, Tian XX, Fang WG (2010) Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 293: 189-97.
109. Toriseva M, Kahari VM (2009) Proteinases in cutaneous wound healing. Cell Mol Life Sci 66: 203-224.
110. Hrafnkelsdottir T, Erlinge D, Jern S (2001) Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thromb Haemost 85: 875-881.
111. Bouchie JL, Chen HC, Carney R, Bagot JC, Wilden PA, Feener EP (2000) P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 866-873.
112. Klepeis VE, Weinger I, Kaczmarek E, Trinkaus-Randall V (2004) P2Y receptors play a critical role in epithelial cell communication and migration. J Cell Biochem 93: 1115-1133.
113. Crooke A, Guzman-Aranguez A, Peral A, Abdurrahman MK, Pintor J (2008) Nucleotides in ocular secretions: their role in ocular physiology. J Pharmacol Ther 119: 55-73.
114. Pintor J, Bautista A, Carracedo G, Peral A (2004) UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea. Ophthalmic Physiol Opt 24: 186-193.
115. Weinger I, Klepeis VE, Trinkaus-Randall V (2005) Tri-nucleotide receptors play a critical role in epithelial cell wound repair. Purinergic Signal 1: 281-292.
116. Mediero A, Peral A, Pintor J (2006) Dual roles of diadenosine polyphosphates in corneal epithelial cell migration. Invest Ophthalmol Vis Sci 47: 4500-4506.
117. Mayo C, Ren R, Rich C, Stepp MA, Trinkaus-Randall V (2008) Regulation by P2X7: epithelial migration and stromal organization in the cornea. Invest Ophthalmol Vis Sci 49: 4384-4391.
118. Brunschweiger A, Müller CE (2006) P2 receptors activated by uracil nucleotides-an update. Curr Med Chem 13: 289-312.
119. Husted S, van Giezen JJ (2009) Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc Ther 27: 259-274.
120. Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673-694.